PNC Financial Services Group’s Xenon Pharmaceuticals XENE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $108K | Sell |
3,462
-1,758
| -34% | -$55K | ﹤0.01% | 2656 |
|
|
2025
Q1 | $175K | Buy |
5,220
+80
| +2% | +$2.68K | ﹤0.01% | 2276 |
|
|
2024
Q4 | $201K | Buy |
5,140
+180
| +4% | +$7.06K | ﹤0.01% | 2208 |
|
|
2024
Q3 | $195K | Buy |
4,960
+120
| +2% | +$4.72K | ﹤0.01% | 2199 |
|
|
2024
Q2 | $189K | Buy |
4,840
+2,160
| +81% | +$84.2K | ﹤0.01% | 2189 |
|
|
2024
Q1 | $115K | Buy |
2,680
+700
| +35% | +$30.1K | ﹤0.01% | 2528 |
|
|
2023
Q4 | $91.2K | Buy |
+1,980
| New | +$91.2K | ﹤0.01% | 2677 |
|
|
2021
Q3 | – | Sell |
-45,722
| Closed | -$851K | – | 4421 |
|
|
2021
Q2 | $851K | Hold |
45,722
| – | – | ﹤0.01% | 1281 |
|
|
2021
Q1 | $818K | Hold |
45,722
| – | – | ﹤0.01% | 1262 |
|
|
2020
Q4 | $703K | Hold |
45,722
| – | – | ﹤0.01% | 1291 |
|
|
2020
Q3 | $506K | Hold |
45,722
| – | – | ﹤0.01% | 1354 |
|
|
2020
Q2 | $573K | Hold |
45,722
| – | – | ﹤0.01% | 1296 |
|
|
2020
Q1 | $518K | Hold |
45,722
| – | – | ﹤0.01% | 1267 |
|
|
2019
Q4 | $599K | Hold |
45,722
| – | – | ﹤0.01% | 1373 |
|
|
2019
Q3 | $412K | Hold |
45,722
| – | – | ﹤0.01% | 1700 |
|
|
2019
Q2 | $451K | Buy |
45,722
+34,022
| +291% | +$336K | ﹤0.01% | 1681 |
|
|
2019
Q1 | $119K | Buy |
+11,700
| New | +$119K | ﹤0.01% | 2455 |
|